关键词：干细胞；抗癌疗法；自我更新；分化
摘 要：Stem cells are undifferentiated cells with self-renewal and differentiation properties. Stem cell products are applied in numerous permutations of methods with the usage of cells, engineering and materials, and appropriate biochemical factors. At present, stem cell-based therapies used in cancer treatment are chiefly of the hematopoietic variety, although at the research level, there is a noteworthy increase in embryonic, pluripotent, and other stem cell therapies. Currently there are no FDA-approved stem cell therapies; however there are a few FDA-approved stem cell therapies that are used adjunctively as part of an oncology therapy. These therapies have either a tissue regenerative effect, a tissue protective effect, or an anti–cancer effect. Stem cells have been used to renew the blood and immune systems impaired by cancer cells or during the treatment of cancer, i.e., by chemotherapy or radiotherapy. Apart from their use in the immunomodulation, stem cells have been proven to contribute to tissue regeneration and as delivery vehicles in the cancer treatment. The recent theory of cancer stem cells has engaged scientific communities towards a different wide new area of research field with possible potential future treatment modalities for cancer. Stem cell therapy is an emerging field and leading pharmaceutical companies are showing considerable interest in this area. Stem cells offer immense potential for treating various untreatable diseases.
目 录： 01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology

Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

06. Stem Cells

06.1 Autologous Cell Therapy

06.2 Allogenic Cell Therapy

07. Market Landscape

07.1 Global Stem Cell Anticancer Therapeutics Market

Market Size and Forecast

07.2 Stem Cell Anticancer Therapeutics Market in the North America

Market Size and Forecast

07.3 Stem Cell Anticancer Therapeutics Market in the Latin and South America .

Market Size and Forecast

07.4 Stem Cell Anticancer Therapeutics Market in Europe

Market Size and Forecast

07.5 Stem Cell Anticancer Therapeutics Market in Asia

Market Size and Forecast

07.6 Five Forces Analysis

08. Geographical Segmentation

09. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis

16.1 Roche Holding AG

Business Overview

Key Information

SWOT Analysis

16.2 OncoMed Pharmaceuticals Inc.

Business Overview

Key Information

SWOT Analysis

16.3 Celgene Corp.

Business Overview

Key Information

SWOT Analysis

16.4 Merck and Co. Inc.

Business Overview

Key Information

SWOT Analysis

17. Other Reports in this Series